Pain Therapeutics receives milestone payment from King Pharmaceuticals
Pain Therapeutics, Inc., a biopharmaceutical company, has received a $5 million milestone payment from King Pharmaceuticals, Inc., its exclusive commercial partner for abuse-resistant prescription pain medications.
NovaDel Pharma Inc. today announced that it has received a $500,000 milestone payment from Akrimax Pharmaceuticals.